The information provided on this website is intended for Healthcare Professionals in the UK only.
If you are a parent or caregiver of a child who has been prescribed Methylphenidate Hydrochloride 2mg/ml oral solution for ADHD, please click here.
If you are interested in finding out more about ADHD, please click here.
Adverse event reporting information can be found at the bottom of the page.
PRESCRIBING INFORMATION
Methylphenidate Hydrochloride 2mg/mL oral Solution
(Methylphenidate hydrochloride).
Please refer to Summary of Product Characteristics (SmPC) before prescribing.
Indication Methylphenidate Hydrochloride 2mg/mL Oral Solution is indicated as part of a comprehensive treatment programme for Attention Deficit / Hyperactivity Disorder (ADHD) in children aged 6 years of age and over and adolescents when remedial measures alone prove insufficient. Treatment must be initiated under the supervision of a specialist in childhood and/or adolescent behavioural disorders. Presentation Methylphenidate Hydrochloride Oral Solution contains the active ingredient methylphenidate at 2mg/mL in solution. Dosage and administration Solution for oral use. Careful dose titration is necessary at the start of treatment with methylphenidate – 5mg once or twice daily increasing the dose and frequency of administration if required by weekly increments of 5-10mg in the daily dose. Doses above 60mg daily are not recommended. Contraindications Hypersensitivity to the active substance or to any of the inactive ingredients. Contraindicated in Glaucoma; phaeochromocytoma; during or within 14 days of discontinuing treatment with MAO; hyperthyroidism or thyrotoxicosis; diagnosis or history of severe depression; anorexia nervosa/anorexic disorders; suicidal tendencies; psychotic symptoms; severe mood disorders; mania, schizophrenia, psychopathic/borderline personality disorder. Please refer to SmPC. Warning and precautions Patients on long term therapy (more than 12 months) require ongoing monitoring for cardiovascular status); for neurological signs and symptoms; for psychiatric/ neurological conditions; for growth. Methylphenidate should be de-challenged at least once yearly to assess the child’s condition. Caution is indicated in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate. Potential for abuse, misuse or diversion in patients with known drug or alcohol dependency. Caution is advised in patients being treated with methylphenidate with any other active substances that can also elevate blood pressure.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk. Adverse events should also be reported to Consilient Health (UK) Ltd, No. 1 Church Road, Richmond upon Thames, Surrey TW9 2QE UK or drugsafety@consilienthealth.com
UK-MPH-45h | September 2025
A short animation giving step-by-step instructions on administering methylphenidate oral solution.
This two minute animation gives simple step-by-step instructions on how to administer your child’s doses of methylphenidate oral solution exactly as prescribed by their doctor. Following these simple steps helps to ensure that your child gets the very most from therapy.
A quick reference guide to ADHD and its treatment with methylphenidate oral solution.
This quick reference guide gives you easily accessible information about ADHD and its treatment with methylphenidate oral solution. This includes simple step-by-step instructions on administering this medicine, as well as answers to frequently asked questions, such as possible side effects to look out for and how to store methylphenidate oral solution.
A fun, interactive way to help children with ADHD find out more about their condition and its treatment.
This comic-style booklet helps children with ADHD to explore their condition and its treatment in a fun, interactive way. The booklet explains how treatment helps kids to make friends with their ADHD, so that they can do lots of things together. There’s easy to understand information about methylphenidate oral solution too, helping your child to understand their treatment and get the very most from it.
This information pack has been developed to provide a central resource that may be used for activities such as completion of a formulary request for Methylphenidate Hydrochloride 2mg/ml oral solution. It contains a wealth of information about this medicine and its place in therapy, from guidelines and recommendations to bioequivalence data and financial considerations vs. immediate-release methylphenidate tablets.
This two minute animation for parents and caregivers of children with ADHD gives simple step-by-step instructions on how to administer doses of Methylphenidate Hydrochloride 2mg/ml oral solution exactly as prescribed. This includes important information to help ensure that treatment is delivered as safely and effectively as possible.
This quick reference guide for parents and caregivers of children with ADHD combines background information on the condition with practical guidance on helping their child to get the very most from treatment with Methylphenidate Hydrochloride 2mg/ml oral solution. This includes step-by-step administration instructions and answers to frequently asked questions.
This quick reference guide provides key information on Methylphenidate Hydrochloride 2mg/ml oral solution, including prescribing considerations, dosage and administration. The guide also includes useful information to share with parents and caregivers of children receiving this medicine, to help ensure that treatment is delivered as safely and effectively as possible.
This highly visual resource takes a fun, interactive approach to helping children with ADHD explore their condition and how it affects them. It presents ADHD as being like a really great friend who can help them to do things when they take the medicine that you have prescribed. Specific child-friendly information about Methylphenidate Hydrochloride 2mg/ml oral solution is included to help patients get the very most from treatment.
